{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:12:39Z","timestamp":1774609959347,"version":"3.50.1"},"reference-count":27,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:00:00Z","timestamp":1763164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,3,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Disopyramide and mavacamten both decrease left ventricular outflow tract gradients in obstructive hypertrophic cardiomyopathy (HCM). Yet, their effects on myocardial mechanics remain unclear. This study aimed to compare the effects of mavacamten and disopyramide on left ventricular mechanical dispersion (LVMD) and its association with life-threatening ventricular arrhythmias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>Consecutive subjects (n = 120) with obstructive HCM treated with either Mavacamten or disopyramide from 2018 to 2024 were identified. Echocardiographic speckle-tracking strain imaging with myocardial work indices and LVMD quantification was performed at baseline and follow-up. Patients were followed up for life-threatening ventricular arrhythmias: sustained ventricular tachycardia (VT) or sudden cardiac arrest (SCA), up to 2 years. Propensity matching was performed for age and sex to compare the groups. Mavacamten significantly reduced LVMD (85.1 \u00b1 26.4\u2005ms vs. 64.3 \u00b1 16.7\u2005ms, P = 0.013) and global wasted work (GWW) (268\u2005mmHg% (185\u2013378) vs. 150\u2005mmHg% (124\u2013262), P = 0.006) and increased global work efficiency (GWE) (87% (82\u201392) vs. 90% (86\u201394), P = 0.038). None of the favourable effects were observed with disopyramide. The median follow-up duration was 12 (range 6\u201324) months. LVMD at follow-up was significantly associated with the outcome events [area under curve: 0.784, 95% CI (0.622\u20130.945), P &amp;lt; 0.001]. LVMD &amp;lt;72\u2005ms at follow-up was associated with improved event-free survival (X6.4, log-rank P = 0.011). Mavacamten and global work indices were independent determinants of LVMD at follow-up.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Mavacamten, but not disopyramide, decreased LVMD, GWW, and increased GWE in obstructive HCM. LVMD &amp;lt;72\u2005ms at follow-up is promising for assessing the risk for life-threatening ventricular arrhythmias.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjci\/jeaf318","type":"journal-article","created":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T13:02:28Z","timestamp":1762952548000},"page":"766-775","source":"Crossref","is-referenced-by-count":1,"title":["Effect of mavacamten and disopyramide on left ventricular mechanical dispersion and life-threatening arrhythmia in obstructive hypertrophic cardiomyopathy"],"prefix":"10.1093","volume":"27","author":[{"given":"Benay","family":"Ozbay","sequence":"first","affiliation":[{"name":"University of Pittsburgh, School of Medicine, Division of Cardiology , Pittsburgh, PA, 15213 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy C","family":"Wong","sequence":"additional","affiliation":[{"name":"University of Pittsburgh, School of Medicine, Division of Cardiology , Pittsburgh, PA, 15213 ,","place":["USA"]},{"name":"University of Pittsburgh Medical Center, UPMC, Heart and Vascular Institute , Pittsburgh, PA, 15213 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N A Mark","family":"Estes","sequence":"additional","affiliation":[{"name":"University of Pittsburgh, School of Medicine, Division of Cardiology , Pittsburgh, PA, 15213 ,","place":["USA"]},{"name":"University of Pittsburgh Medical Center, UPMC, Heart and Vascular Institute , Pittsburgh, PA, 15213 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William E","family":"Katz","sequence":"additional","affiliation":[{"name":"University of Pittsburgh, School of Medicine, Division of Cardiology , Pittsburgh, PA, 15213 ,","place":["USA"]},{"name":"University of Pittsburgh Medical Center, UPMC, Heart and Vascular Institute , Pittsburgh, PA, 15213 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew S","family":"Suffoletto","sequence":"additional","affiliation":[{"name":"University of Pittsburgh, School of Medicine, Division of Cardiology , Pittsburgh, PA, 15213 ,","place":["USA"]},{"name":"University of Pittsburgh Medical Center, UPMC, Heart and Vascular Institute , Pittsburgh, PA, 15213 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genise","family":"Green","sequence":"additional","affiliation":[{"name":"University of Pittsburgh Medical Center, UPMC, Heart and Vascular Institute , Pittsburgh, PA, 15213 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth M","family":"Luttner","sequence":"additional","affiliation":[{"name":"University of Pittsburgh Medical Center, UPMC, Heart and Vascular Institute , Pittsburgh, PA, 15213 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3737-8595","authenticated-orcid":false,"given":"Leyla Elif","family":"Sade","sequence":"additional","affiliation":[{"name":"University of Pittsburgh, School of Medicine, Division of Cardiology , Pittsburgh, PA, 15213 ,","place":["USA"]},{"name":"University of Pittsburgh Medical Center, UPMC, Heart and Vascular Institute , Pittsburgh, PA, 15213 ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,11,15]]},"reference":[{"key":"2026032620514339500_jeaf318-B1","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1016\/j.jacc.2024.02.014","article-title":"2024 AHA\/ACC\/AMSSM\/HRS\/PACES\/SCMR guideline for the management of hypertrophic cardiomyopathy: a report of the American Heart Association\/American College of Cardiology joint committee on clinical practice guidelines","volume":"83","author":"Ommen","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"2026032620514339500_jeaf318-B2","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","article-title":"Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Marian","year":"2017","journal-title":"Circ Res"},{"key":"2026032620514339500_jeaf318-B3","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1126\/science.aad3456","article-title":"A small molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice","volume":"351","author":"Green","year":"2016","journal-title":"Science"},{"key":"2026032620514339500_jeaf318-B4","doi-asserted-by":"crossref","first-page":"E7486","DOI":"10.1073\/pnas.1720342115","article-title":"Mavacamten stabilizes an autoinhibited state of two-headed cardiac myosin","volume":"115","author":"Rohde","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026032620514339500_jeaf318-B5","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1016\/j.jacc.2021.09.1381","article-title":"Effect of mavacamten on echocardiographic features in symptomatic patients with obstructive hypertrophic cardiomyopathy","volume":"78","author":"Hegde","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"2026032620514339500_jeaf318-B6","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/S0140-6736(20)31792-X","article-title":"EXPLORER-HCM study investigators. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo controlled, phase 3 trial","volume":"396","author":"Olivotto","year":"2020","journal-title":"Lancet"},{"key":"2026032620514339500_jeaf318-B7","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/jamacardio.2023.3342","article-title":"Mavacamten in patients with hypertrophic cardiomyopathy referred for septal reduction: week 56 results from the VALOR-HCM randomized clinical trial","volume":"8","author":"Desai","year":"2023","journal-title":"JAMA Cardiol"},{"key":"2026032620514339500_jeaf318-B8","doi-asserted-by":"crossref","first-page":"100622","DOI":"10.1016\/j.jacadv.2023.100622","article-title":"Medical therapies to improve left ventricular outflow obstruction and diastolic function in hypertrophic cardiomyopathy","volume":"2","author":"Zhu","year":"2023","journal-title":"JACC Adv"},{"key":"2026032620514339500_jeaf318-B9","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/eurheartj\/ehs016","article-title":"A novel clinical method for quantification of regional left ventricular pressure-strain loop area: a noninvasive index of myocardial work","volume":"33","author":"Russell","year":"2012","journal-title":"Eur Heart J"},{"key":"2026032620514339500_jeaf318-B10","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jcmg.2019.03.025","article-title":"Prediction of ventricular arrhythmias with left ventricular mechanical dispersion: a systematic review and meta-analysis","volume":"13","author":"Kawakami","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"2026032620514339500_jeaf318-B11","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/ehjci\/jew005","article-title":"Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy","volume":"17","author":"Haland","year":"2016","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026032620514339500_jeaf318-B12","doi-asserted-by":"crossref","first-page":"e011188","DOI":"10.1161\/CIRCHEARTFAILURE.123.011188","article-title":"Long-term effects of mavacamten on electromechanical dispersion and deformation in obstructive hypertrophic cardiomyopathy","volume":"17","author":"Del Franco","year":"2024","journal-title":"Circ Heart Fail"},{"key":"2026032620514339500_jeaf318-B13"},{"key":"2026032620514339500_jeaf318-B14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/ehjci\/jey042","article-title":"Standardization of left atrial, right ventricular, and right atrial deformation imaging using two-dimensional speckle tracking echocardiography: a consensus document of the EACVI\/ASE\/industry task force to standardize deformation imaging","volume":"19","author":"Badano","year":"2018","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026032620514339500_jeaf318-B15","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1093\/eurheartj\/ehn466","article-title":"Left ventricular mechanical dispersion by tissue Doppler imaging: a novel approach for identifying high-risk individuals with long QT syndrome","volume":"30","author":"Haugaa","year":"2009","journal-title":"Eur Heart J"},{"key":"2026032620514339500_jeaf318-B16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1093\/ehjci\/jeaa301","article-title":"How to measure left ventricular myocardial work by pressure-strain loops","volume":"22","author":"Smiseth","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026032620514339500_jeaf318-B17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/ehjci\/jead236","article-title":"Non-invasive estimation of left ventricular systolic peak pressure: a prerequisite to calculate myocardial work in hypertrophic obstructive cardiomyopathy","volume":"25","author":"Batzner","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"2026032620514339500_jeaf318-B18","first-page":"e272","article-title":"2017 AHA\/ACC\/HRS guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"key":"2026032620514339500_jeaf318-B19","doi-asserted-by":"crossref","first-page":"5609","DOI":"10.1111\/bph.15271","article-title":"Effects of mavacamten on Ca2 + sensitivity of contraction as sarcomere length varied in human myocardium","volume":"177","author":"Awinda","year":"2020","journal-title":"Br J Pharmacol"},{"key":"2026032620514339500_jeaf318-B20","doi-asserted-by":"crossref","first-page":"H881","DOI":"10.1152\/ajpheart.00345.2020","article-title":"Mavacamten decreases maximal force and Ca2 + sensitivity in the N47K-myosin regulatory light chain mouse model of hypertrophic cardiomyopathy","volume":"320","author":"Awinda","year":"2021","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2026032620514339500_jeaf318-B21","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jacbts.2019.06.004","article-title":"Electrophysiological and contractile effects of disopyramide in patients with obstructive hypertrophic cardiomyopathy: a translational study","volume":"4","author":"Coppini","year":"2019","journal-title":"JACC Basic Transl Sci"},{"key":"2026032620514339500_jeaf318-B22","doi-asserted-by":"crossref","first-page":"116036","DOI":"10.1016\/j.biopha.2023.116036","article-title":"Biomechanical response of ultrathin slices of hypertrophic cardiomyopathy tissue to myosin modulator mavacamten","volume":"170","author":"Amesz","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"2026032620514339500_jeaf318-B23","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.pcad.2012.04.003","article-title":"A primer of disopyramide treatment of obstructive hypertrophic cardiomyopathy","volume":"54","author":"Sherrid","year":"2012","journal-title":"Prog Cardiovasc Dis"},{"key":"2026032620514339500_jeaf318-B24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/toxsci\/kfz235","article-title":"Detection of drug-induced torsades de pointes arrhythmia mechanisms using hiPSC-CM syncytial monolayers in a high-throughput screening voltage sensitive dye assay","volume":"173","author":"da Rocha","year":"2020","journal-title":"Toxicol Sci"},{"key":"2026032620514339500_jeaf318-B25","doi-asserted-by":"crossref","first-page":"e005152","DOI":"10.1161\/JAHA.116.005152","article-title":"Safety of outpatient initiation of disopyramide for obstructive hypertrophic cardiomyopathy patients","volume":"6","author":"Adler","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"2026032620514339500_jeaf318-B26","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1001\/jamacardio.2019.1391","article-title":"Enhanced American College of Cardiology\/American Heart Association strategy for prevention of sudden cardiac death in high-risk patients with hypertrophic cardiomyopathy","volume":"4","author":"Maron","year":"2019","journal-title":"JAMA Cardiol"},{"key":"2026032620514339500_jeaf318-B27","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.jcmg.2019.10.009","article-title":"Software variability in measurement of LV mechanical dispersion in patients with LV hypertrophy","volume":"13","author":"Saijo","year":"2020","journal-title":"JACC Cardiovasc Imaging"}],"container-title":["European Heart Journal - Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/advance-article-pdf\/doi\/10.1093\/ehjci\/jeaf318\/65292379\/jeaf318.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/advance-article-pdf\/doi\/10.1093\/ehjci\/jeaf318\/65292379\/jeaf318.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/advance-article-pdf\/doi\/10.1093\/ehjci\/jeaf318\/65292379\/jeaf318.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:51:53Z","timestamp":1774572713000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcimaging\/article\/27\/4\/766\/8323508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,15]]},"references-count":27,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,11,15]]},"published-print":{"date-parts":[[2026,3,27]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjci\/jeaf318","relation":{},"ISSN":["2047-2404","2047-2412"],"issn-type":[{"value":"2047-2404","type":"print"},{"value":"2047-2412","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,4]]},"published":{"date-parts":[[2025,11,15]]}}}